{
    "contributors": null,
    "coordinates": null,
    "created_at": "Tue Oct 06 19:25:34 +0000 2015",
    "entities": {
        "hashtags": [],
        "symbols": [],
        "urls": [
            {
                "display_url": "ow.ly/T5EjT",
                "expanded_url": "http://ow.ly/T5EjT",
                "indices": [
                    101,
                    123
                ],
                "url": "http://t.co/URATwxq4Zx"
            }
        ],
        "user_mentions": [
            {
                "id": 34010976,
                "id_str": "34010976",
                "indices": [
                    0,
                    8
                ],
                "name": "Bristol-Myers Squibb",
                "screen_name": "bmsnews"
            }
        ]
    },
    "favorite_count": 0,
    "favorited": false,
    "geo": null,
    "id": 651478421491568640,
    "id_str": "651478421491568640",
    "in_reply_to_screen_name": "bmsnews",
    "in_reply_to_status_id": null,
    "in_reply_to_status_id_str": null,
    "in_reply_to_user_id": 34010976,
    "in_reply_to_user_id_str": "34010976",
    "is_quote_status": false,
    "lang": "es",
    "metadata": {
        "iso_language_code": "es",
        "result_type": "recent"
    },
    "place": null,
    "possibly_sensitive": false,
    "retweet_count": 0,
    "retweeted": false,
    "source": "<a href=\"http://www.hootsuite.com\" rel=\"nofollow\">Hootsuite</a>",
    "text": "@bmsnews Opdivo (nivolumab) Demonstrates Superior Renal Cell Carcinoma Survival in a Phase 3 Trial - http://t.co/URATwxq4Zx",
    "truncated": false,
    "user": {
        "contributors_enabled": false,
        "created_at": "Sat Jun 14 17:28:41 +0000 2008",
        "default_profile": false,
        "default_profile_image": false,
        "description": "Medelis is a specialized oncology CRO focused on clinical trials in the US and Europe. We provide oncology expertise and a true partner for your trial.",
        "entities": {
            "description": {
                "urls": []
            },
            "url": {
                "urls": [
                    {
                        "display_url": "medelis.com",
                        "expanded_url": "http://www.medelis.com",
                        "indices": [
                            0,
                            22
                        ],
                        "url": "http://t.co/2NcLJfNcbG"
                    }
                ]
            }
        },
        "favourites_count": 14,
        "follow_request_sent": false,
        "followers_count": 1251,
        "following": false,
        "friends_count": 909,
        "geo_enabled": false,
        "has_extended_profile": false,
        "id": 15118311,
        "id_str": "15118311",
        "is_translation_enabled": false,
        "is_translator": false,
        "lang": "en",
        "listed_count": 51,
        "location": "US and Europe",
        "name": "Medelis: OncologyCRO",
        "notifications": false,
        "profile_background_color": "022330",
        "profile_background_image_url": "http://abs.twimg.com/images/themes/theme15/bg.png",
        "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme15/bg.png",
        "profile_background_tile": false,
        "profile_banner_url": "https://pbs.twimg.com/profile_banners/15118311/1431717689",
        "profile_image_url": "http://pbs.twimg.com/profile_images/55454152/medelis_symbol_128_normal.jpg",
        "profile_image_url_https": "https://pbs.twimg.com/profile_images/55454152/medelis_symbol_128_normal.jpg",
        "profile_link_color": "0084B4",
        "profile_sidebar_border_color": "FFFFFF",
        "profile_sidebar_fill_color": "C0DFEC",
        "profile_text_color": "333333",
        "profile_use_background_image": true,
        "protected": false,
        "screen_name": "oncologycro",
        "statuses_count": 363,
        "time_zone": "Central Time (US & Canada)",
        "url": "http://t.co/2NcLJfNcbG",
        "utc_offset": -18000,
        "verified": false
    }
}